The cluster is dominated by quant funds, which may be responding to price momentum or mean-reversion signals rather than a fundamental catalyst. Monitor for any fundamental catalyst (earnings, product news) that could explain the quant buying.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 11 $15.47entry
- T+1 · 5mo ago −2.00%α −2.54% · $15.16
- T+5 · 5mo ago −8.40%α −8.84% · $14.17
- T+20 · 4mo ago −2.71%α −4.61% · $15.05
- T+60 · 2mo ago +50.52%α +46.12% · $23.29
How similar events traded
Executive Summary
Four institutional investors (D.E. Shaw, Citadel, Two Sigma, UBS) significantly increased their MMED positions in Q3 2025, adding a net $9.2M in holdings, while two mega-passive sellers (Morgan Stanley, BofA) trimmed modestly. The cluster is dominated by quantitative funds, suggesting a shared algorithmic or factor-based thesis rather than a fundamental catalyst.
Key Financial Metrics
Institutional Positions
Net institutional flow: $7.6M
▲ Buyers (4)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| D.E. Shaw | DOUBLED | +268.1% | $2.6M | $2.2M |
| Citadel | ADD | +90.1% | $4.0M | $2.8M |
| Two Sigma | DOUBLED | +424.9% | $3.5M | $3.1M |
| Ubs Am, A Distinct Business Un | DOUBLED | +178.3% | $1.4M | $1.1M |
▼ Sellers (2)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | TRIM | -28% | $4.5M | -$1.4M |
| BofA | TRIM | -29.5% | $774.0K | -$217.0K |
Key Facts
- 4 buyers added $9.2M in net new holdings; 2 sellers reduced by $1.6M (net cluster inflow ~$7.6M).
- Three of four buyers are quantitative funds (D.E. Shaw, Citadel, Two Sigma), signal may be factor-driven, not fundamental.
- Morgan Stanley and BofA trimmed ~28-30% of their positions, but their dollar values increased due to stock price appreciation.
- Total institutional buying ($11.4M current holdings) is ~0.3% of MMED's $4.1B market cap, modest scale.
Financial Impact
Net institutional inflow of approximately $7.6M (buyers added $9.2M, sellers reduced $1.6M), representing about 0.2% of market cap.
Risk Factors
- Quantitative buying may be short-term and already unwound given the 45-day 13F reporting lag.
- Passive selling by Morgan Stanley and BofA could indicate index rebalancing or risk reduction.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-MMED-2025-Q3 |
Track record
25 reports on MMED
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today 8-K Mixed 6/10 Entry $18.77 settles Dec 15
- Nov 16, 2026today Press Release Bullish 7/10 Entry $18.81 settles Dec 15
- Nov 6, 202610d ago SC 13G Neutral 4/10 Entry $16.71 settles Dec 7
- Oct 22, 202625d ago SC 13G Neutral 4/10 Entry $18.34 settles Nov 20
- Oct 16, 20264w ago SC 13G/A Neutral 4/10 Entry $17.79 to $18.65 ▲ +4.83% +8.30% vs SPY
- Oct 16, 20264w ago 8-K Neutral 6/10 Entry $17.49 to $17.99 ▲ +2.86% +4.02% vs SPY
- Oct 6, 20265w ago EFFECT Neutral 3/10 Entry $19.64 to $18.85 ▼ −4.02% −0.85% vs SPY
- Oct 1, 20266w ago 3 Neutral 2/10 Entry $19.70 to $18.28 ▼ −7.21% −5.40% vs SPY
- Sep 14, 20269w ago 425 Neutral 4/10 Entry $21.97 to $18.80 ▼ −14.43% −16.69% vs SPY
- Sep 14, 20269w ago 425 Neutral 4/10 Entry $21.97 to $18.80 ▼ −14.43% −16.69% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers